Human adipose tissue e derived mesenchymal stromal cells promote
暂无分享,去创建一个
E. Lombardo | Ramón Menta | Pablo Mancheño‐Corvo | W. Dalemans | O. Delarosa | L. Barrio | Y. Carrasco | V. Cuevas
[1] Manuel D. Díaz-Muñoz,et al. Cyclooxygenase-2 Deficiency in Macrophages Leads to Defective p110γ PI3K Signaling and Impairs Cell Adhesion and Migration , 2013, The Journal of Immunology.
[2] Lev Silberstein,et al. Differential Stem and Progenitor Cell Trafficking by Prostaglandin E2 , 2013, Nature.
[3] J. Grinyó,et al. Immunomodulatory Effect of Mesenchymal Stem Cells on B Cells , 2012, Front. Immun..
[4] E. Lombardo,et al. APRIL and BAFF proteins increase proliferation of human adipose-derived stem cells through activation of Erk1/2 MAP kinase. , 2012, Tissue engineering. Part A.
[5] Yufang Shi,et al. How mesenchymal stem cells interact with tissue immune responses. , 2012, Trends in immunology.
[6] Koji Watanabe,et al. IL-21–Dependent B Cell Death Driven by Prostaglandin E2, a Product Secreted from Follicular Dendritic Cells , 2011, The Journal of Immunology.
[7] S. Morbelli,et al. Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells , 2011, Proceedings of the National Academy of Sciences.
[8] T. Ritter,et al. Mesenchymal stem cell effects on T-cell effector pathways , 2011, Stem Cell Research & Therapy.
[9] A. Marshak‐Rothstein,et al. Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. , 2011, Seminars in immunology.
[10] R. Yañez,et al. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells. , 2010, Experimental cell research.
[11] M. Shlomchik. Activating systemic autoimmunity: B's, T's, and tolls. , 2009, Current opinion in immunology.
[12] E. Lombardo,et al. Toll-like receptor-mediated signaling in human adipose-derived stem cells: implications for immunogenicity and immunosuppressive potential. , 2009, Tissue engineering. Part A.
[13] L. Moretta,et al. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. , 2009, Blood.
[14] S. Itakura,et al. Mesenchymal stem cells suppress B-cell terminal differentiation. , 2009, Experimental hematology.
[15] Yufang Shi,et al. Species Variation in the Mechanisms of Mesenchymal Stem Cell‐Mediated Immunosuppression , 2009, Stem cells.
[16] A. Uccelli,et al. Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.
[17] B. Blanco,et al. The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes , 2008, Haematologica.
[18] S. Kyurkchiev,et al. Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen‐stimulated B‐cell immunoglobulin production in vitro , 2008, Cell biology international.
[19] E. Lefèvre,et al. BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells. , 2008, Blood.
[20] R. Zhao,et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell Stem Cell.
[21] J. Cyster,et al. Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function. , 2008, Seminars in immunology.
[22] L. Moretta,et al. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. , 2008, Blood.
[23] V. Levitsky,et al. Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes , 2007, Journal of leukocyte biology.
[24] O. Ringdén,et al. Mesenchymal Stem Cells Stimulate Antibody Secretion in Human B Cells , 2007, Scandinavian journal of immunology.
[25] J. Edwards,et al. B-cell targeting in rheumatoid arthritis and other autoimmune diseases , 2006, Nature Reviews Immunology.
[26] T. Luft,et al. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. , 2002, Blood.
[27] B. Koller,et al. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. , 2001, The Journal of clinical investigation.
[28] A. Zlotnik,et al. Chemokines: a new classification system and their role in immunity. , 2000, Immunity.
[29] C. Martínez-A,et al. Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells. , 1997, Journal of immunology.
[30] K. Matsushima,et al. Chemotaxis and IL-8 receptor expression in B cells from normal and HIV-infected subjects. , 1997, Journal of immunology.
[31] A Orfao,et al. Human peripheral blood B‐cell compartments: A crossroad in B‐cell traffic , 2010, Cytometry. Part B, Clinical cytometry.
[32] Yoshiro Kobayashi. The role of chemokines in neutrophil biology. , 2008, Frontiers in bioscience : a journal and virtual library.
[33] F. Benvenuto,et al. Human mesenchymal stem cells modulate B-cell functions. , 2006, Blood.
[34] J. Frydenberg,et al. CD19-selected B lymphocytes synthesize, secrete and migrate in the presence of IL-8. TNF-alpha and gammaIP-10 are also B lymphocyte migratory factors. , 1997, Cytokine.